These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8725172)

  • 21. Interleukin-6 is produced by bone and modulated by parathyroid hormone.
    Feyen JH; Elford P; Di Padova FE; Trechsel U
    J Bone Miner Res; 1989 Aug; 4(4):633-8. PubMed ID: 2816508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukaemia inhibitory factor and bone cell function.
    Martin TJ; Allan EH; Evely RS; Reid IR
    Ciba Found Symp; 1992; 167():141-50; discussion 150-5. PubMed ID: 1425010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both N- and C-terminal domains of parathyroid hormone-related protein increase interleukin-6 by nuclear factor-kappa B activation in osteoblastic cells.
    Guillén C; Martínez P; de Gortázar AR; Martínez ME; Esbrit P
    J Biol Chem; 2002 Aug; 277(31):28109-17. PubMed ID: 12000745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemia inhibitory factor (LIF) inhibits basal bone resorption in fetal rat long bone cultures.
    Lorenzo JA; Sousa SL; Leahy CL
    Cytokine; 1990 Jul; 2(4):266-71. PubMed ID: 2129503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential.
    Hara M; Liu YM; Zhen L; Cohen IS; Yu H; Danilo P; Ogino K; Bilezikian JP; Rosen MR
    Circulation; 1997 Nov; 96(10):3704-9. PubMed ID: 9396474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid hormone induces expression and proteolytic processing of Rankl in primary murine osteoblasts.
    Heckt T; Keller J; Peters S; Streichert T; Chalaris A; Rose-John S; Mell B; Joe B; Amling M; Schinke T
    Bone; 2016 Nov; 92():85-93. PubMed ID: 27554428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle.
    Kurek JB; Nouri S; Kannourakis G; Murphy M; Austin L
    Muscle Nerve; 1996 Oct; 19(10):1291-301. PubMed ID: 8808655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukaemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation.
    Brown MA; Metcalf D; Gough NM
    Cytokine; 1994 May; 6(3):300-9. PubMed ID: 8054487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology induced by leukemia inhibitory factor.
    Ryffel B
    Int Rev Exp Pathol; 1993; 34 Pt B():69-72. PubMed ID: 8458718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of leukaemia inhibitory factor in skin of patients with amyotrophic lateral sclerosis.
    Hu J; Imai T; Shimizu N; Nakagawa H; Ono S
    Lancet; 1999 Jun; 353(9170):2126-7. PubMed ID: 10382701
    [No Abstract]   [Full Text] [Related]  

  • 31. Transmembrane potentials of osteoblasts.
    Jeansonne BG; Feagin FF; Shoemaker RL; Rehm WS
    J Dent Res; 1978 Feb; 57(2):361-4. PubMed ID: 277536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth factor control of type II cell apoptosis.
    Hastings RH; Summers-Torres D; Burton D; Deftos L
    Chest; 1999 Jul; 116(1 Suppl):68S. PubMed ID: 10424598
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteoblasts as leukemia-initiating cells.
    Frisch BJ; Calvi LM
    Bonekey Rep; 2014; 3():572. PubMed ID: 25228985
    [No Abstract]   [Full Text] [Related]  

  • 34. Protein kinase inhibitor γ reciprocally regulates osteoblast and adipocyte differentiation by downregulating leukemia inhibitory factor.
    Chen X; Hausman BS; Luo G; Zhou G; Murakami S; Rubin J; Greenfield EM
    Stem Cells; 2013 Dec; 31(12):2789-99. PubMed ID: 23963683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone.
    Cho SW; Pirih FQ; Koh AJ; Michalski M; Eber MR; Ritchie K; Sinder B; Oh S; Al-Dujaili SA; Lee J; Kozloff K; Danciu T; Wronski TJ; McCauley LK
    J Biol Chem; 2013 Mar; 288(10):6814-25. PubMed ID: 23297399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration.
    Berruti A; Cook R; Saad F; Buttigliero C; Lipton A; Tampellini M; Lee KA; Coleman RE; Smith MR
    Oncologist; 2012; 17(5):645-52. PubMed ID: 22523198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells.
    Novince CM; Koh AJ; Michalski MN; Marchesan JT; Wang J; Jung Y; Berry JE; Eber MR; Rosol TJ; Taichman RS; McCauley LK
    Am J Pathol; 2011 Nov; 179(5):2431-42. PubMed ID: 21939632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective.
    Barkhordarian A; Ajaj R; Ramchandani MH; Demerjian G; Cayabyab R; Danaie S; Ghodousi N; Iyer N; Mahanian N; Phi L; Giroux A; Manfrini E; Neagos N; Siddiqui M; Cajulis OS; Brant XM; Shapshak P; Chiappelli F
    Patholog Res Int; 2011; 2011():359242. PubMed ID: 21660263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of anti-parathyroid hormone-related protein monoclonal antibody and osteoprotegerin on PTHrP-producing tumor-induced cachexia in nude mice.
    Iguchi H; Aramaki Y; Maruta S; Takiguchi S
    J Bone Miner Metab; 2006; 24(1):16-9. PubMed ID: 16369893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PTH and PTHrP effects on the skeleton.
    Karaplis AC; Goltzman D
    Rev Endocr Metab Disord; 2000 Nov; 1(4):331-41. PubMed ID: 11706747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.